Chobert MN et al LIVER PRECURSOR CELLS INCREASE HEPATIC FIBROSIS INDUCED BY CHRONIC CARBON TETRACHLORIDE INTOXICATION IN RAT

Hepatic fibrosis, the major complication of virtually all types of chronic liver damage, usually begins in portal areas, and its severity has been correlated to liver progenitor cells (LPC) expansion from periportal areas, even if the primary targets of injury are intralobular hepatocytes. The aim of this study was to determine the potential fibrogenic role of LPC, using a new experimental model in which rat liver fibrosis was induced by chronic carbon tetrachloride (CCl4) administration for 6 weeks, in combination with chronic acetylaminofluorene treatment (AAF), which promotes activation of LPC compartment. Treatment with CCl4 alone caused a significant increase in serum transaminase activity as well as liver fibrosis initiating around central veins and leading to formation of incomplete centro-central septa with sparse fibrogenic cells expressing-smooth muscle actin (SMA). In AAF/CCl4-treated animals, the fibrogenic response was profoundly worsened, with formation of multiple porto-central bridging septa leading to cirrhosis, whereas hepatocellular necrosis and inflammation were similar to those observed in CCl4-treated animals. Enhanced fibrosis in AAF/CCl4 group was accompanied by ductule forming LPC expanding from portal areas, αSMA-positive cells accumulation in the fibrotic areas and increased expression of hepatic collagen type 1, 3 and 4 mRNA. Moreover, CK19-positive LPC expressed the most potent fibrogenic cytokine transforming growth factor-β (TGF without any expression of SMA, desmin or fibroblast-specific protein-1, demonstrating that LPC did not undergo an epithelialmesenchymal transition. In this new experimental model, LPC, by expressing TGF contributed to the accumulation of SMA-positive myofibroblasts in the ductular reaction leading to enhanced fibrosis but also to disease progression and to a fibrotic pattern similar to that observed in human. List of abbreviations: SMA,-smooth muscle actin; AAF, acetylaminofluorene; AFP, -fetoprotein; ALT, alanine aminotransferase; CCl4, carbon tetrachloride; CK19, cytokeratin 19; CCR2, chemokine C-C motif receptor 2; EMT, epithelial-mesenchymal transition; HSC, hepatic stellate cells; LPC, liver progenitor cells; TGFtransforming growth factor-β; TNFtumor necrosis factor-.